Selpercatinib and Body Composition
NCT07543887 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2026-04-22
Summary
investigation of body composition
Conditions
Interventions
- OTHER
-
observation in patient under treatment
observation in patient under treatment
- DRUG
-
observational study of patients under selpercatinib
Sponsors & Collaborators
-
University of Pisa
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-12
- Primary Completion
- 2026-04-04
- Completion
- 2026-04-04
- FDA Drug
- Yes
Countries
- Italy
Study Locations
More Related Trials
-
SEntine Lymph Node in earLY Ovarian Cancer (SELLY)
NCT03563781 ·Status: COMPLETED ·Phase: NA
-
Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer
NCT00061906 ·Status: COMPLETED ·Phase: PHASE2
-
Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
NCT00052611 ·Status: COMPLETED ·Phase: PHASE2
-
Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
NCT00101335 ·Status: COMPLETED ·Phase: PHASE2
-
Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
NCT00357617 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma
NCT02537925 ·Status: UNKNOWN ·Phase: PHASE3
-
Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS
NCT05180942 ·Status: RECRUITING
-
Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer
NCT00068653 ·Status: COMPLETED ·Phase: PHASE2
-
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
NCT04162873 ·Status: TERMINATED ·Phase: PHASE2
-
Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC
NCT00181532 ·Status: COMPLETED ·Phase: PHASE2
-
Understanding and Anticipating Therapeutic Response And Immuno-meDIated Adverse Events in Anti-cancer Immune-checkpoint Inhibition: a Tissue Biopsy Based imaGing Study
NCT05921123 ·Status: RECRUITING
-
S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women
NCT00088972 ·Status: TERMINATED ·Phase: PHASE2
-
Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor
NCT00314262 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients
NCT04811196 ·Status: COMPLETED ·Phase: PHASE1
-
Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer
NCT00581971 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immune System Modulation and Outcome in High-risk cSCC Treated With Surgery and Radiotherapy
NCT05246228 ·Status: NOT_YET_RECRUITING
-
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06349642 ·Status: RECRUITING
-
An Open Label Phase II Study Combining Nivolumab and Celecoxib in Patients With Advanced " Cold " Solid Tumors
NCT03864575 ·Status: UNKNOWN ·Phase: PHASE2
-
Cetuximab and Lenalidomide in Head and Neck
NCT01133665 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer
NCT01695226 ·Status: COMPLETED ·Phase: PHASE2
-
Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer
NCT00137852 ·Status: COMPLETED ·Phase: PHASE2
-
Magnetic Localization of Sentinel Nodes in Squamous Cell Oral Carcinoma.
NCT06261983 ·Status: RECRUITING
-
A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy
NCT00328432 ·Status: COMPLETED ·Phase: PHASE1
-
Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance
NCT03666325 ·Status: UNKNOWN ·Phase: PHASE2
-
Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
NCT00058006 ·Status: COMPLETED ·Phase: PHASE2